Med Tech
Company reports

Books on medical technology

Business news

Nexstim’s navigated brain stimulation for neurosurgery planning receives FDA approval
Nexstim Oy, a medical device company has received US FDA appproval for its navigated brain stimulation system for use in the assessment of the primary motor cortex for pre-procedural planning. 17 December 2009

ATS Medical gains CE approval for ATS 3f Enable aortic valve
platform that combines the novel 3f tubular pericardial valve design with its superior hemodynamic profiles and a self-expanding frame to hold the valve in its optimal position. 17 Dec 2009

European 'incubator' to accelerate medical device development launched
The European Medical Device Accelerator (MDA) based at the Science Park next to Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland, aims to accelerate the development of revolutionary medical device technology ideas in Europe. 15 December 2009

Lifebridge gains FDA clearance for cardio-pulmonary support device
German-based Lifebridge AG has received clearance from the US FDA for a compact, lightweight, mobile heart-lung machine, a first for any manufacturer worldwide. 15 Dec 2009

Open source initiative offers cheaper, rapid development path for medical devices
A unique medical innovation initiative launched by Cranfield University could shape the way the medical device sector introduces new innovations. 4 December 2009

Toumaz Technology named emerging technology company of the year
Toumaz Technology Limited, producer of ultra-low power wireless infrastructure for body monitoring solutions has been named “Emerging Technology Company of the Year” by the National Microelectronics Institute (NMI), the premier trade association representing the semiconductor industry in the UK and Ireland.

Nolato Medical expands Swedish Technology Centre
Nolato Medical is expanding its Technology Centre in southern Sweden to meet increased demand from its customers for more complex medical device product development. 25 Nov 2009

Olympus opens technology centre for high energy medical products in Czech Republic
Olympus subsidiary Olympus Winter & Ibe has opened a new  technology centre in the Czech city of Přerov to manufacture products such as high-frequency generators, applicators for bipolar high-frequency ablation, electrodes for urology, and electrical instruments used in surgery.

PPD to Acquire Excel PharmaStudies
Global contract research organization PPD, Inc. is to acquire Chinese company Excel PharmaStudies, Inc. a market leader and one of the largest contract research organizations in China. 12 November 2009

Manhattan Scientifics and Senior Scientifics collaborate to develop cancer cell detection system
Manhattan Scientifics and Senior Scientific, LLC are co-operating to commercialize Senior Scientific’s magnetic needle leukemia cancer cell detection invention based on the use of nanoparticles. 12 November 2009

Agilent and Stanford University to build breakthrough sub 10 nanometre scale devices
Agilent Technologies Inc. (NYSE: A) is collaborating with Stanford University to study using scanning probe microscope and atomic layer deposition to build devices with breakthroughs in sub 10 nm scale 12. November 2009

Boston Scientific launches Promus Element Stent System in Europe
Boston Scientific has announced EU approval and the launch in Europe of its Promus Element Everolimus-eluting coronary stent system. 3 Nov 2009

Abbott completes acquisition of Evalve
Abbott (NYSE:ABT) has announced that it has completed its acquisition of Evalve, Inc., a developer of devices for minimally invasive repair of mitral valves. 3 Nov 2009

Eurogentec to acquire proteomics developer AnaSpec
Belgian biotechnology lab products supplier Eurogentec S.A. has announced it has entered a final agreement for the acquisition of california protemics developer AnaSpec, Inc. 30 October 2009

Microbix and Hunan Biopharmaceutical to build Asia's largest flu vaccine facility
Canadian vaccine technology company Microbix, has signed a joint venture agreement with the Hunan Biopharmaceutical Co. Ltd. for initial financing to construct a vaccine production facility with capacity for 100m doses of seasonal flu and 300m doses of pandemic flu. 27 Oct 2009

Sinovac obtains third H1N1 vaccine order from Chinese Government
Sinovac Biotech Ltd. (NYSE:SVA), a leading provider of biopharmaceutical products in China, has received its third purchase order for its H1N1 vaccine, PANFLU.1, from China's Ministry of Industry and Information Technology for the national stockpiling plan. 29 Oct 2009

eBioscience acquires Bender MedSystems' immunoassay technology
eBioscience Corporation has acquired privately held Austrian immunoassay technology pioneer Bender MedSystems GmbH in an all cash transaction. 29 Oct 2009

GE Launches $250m Healthymagination Fund for healthcare technology ventures
GE's new equity fund will make investments in highly promising healthcare technology companies globally that have innovative diagnostic, IT, and life sciences technologies. 27 October 2009

Siemens integrates Trumpf’s OR table in its Artis angiography systems
Siemens Healthcare has integrated the TruSystem7500 operating table from Trumpf with its C-arm systems Artis zee ceiling and Artis zeego. 27 October 2009

Devlin Electronics to launch Medical division at Medica
Devlin Medical will be launched at the Medica Exhibition in Dusseldorf in November (18-21). Devlin Medical is dedicated to the development of innovative point-of-care computing systems. 27 October 2009.

3M Drug Delivery Systems expands with new Singapore lab
The Singapore lab will develop products in both the inhalation and transdermal drug-delivery categories for pharmaceutical customers and patients in the Asia Pacific region. 23 October 2009

Kinaxo and Bayer Vital collaborate in cancer biomarker identification
Kinaxo will apply its quantitative phosphoproteomics technology PhosphoScout for the identification of novel biomarkers in a clinical trial conducted by Bayer Vital. 21 Oct 2009

Siemens wins $135 million service contract from US health system
The University of Pennsylvania Health System has awarded Siemens Healthcare a $135 million contract for integrated service management for diagnostic systems and bio-medical devices. 21 Oct 2009 Deutsch

Medifacts wins $2.7m contract for cardiac monitoring in clinical trial
Medifacts International Inc, has been awarded the contract to provide comprehensive cardiac safety and efficacy services for a large late-stage clinical trial. 20 Oct 2009

Medical Equipment Industry Deals Analysis — September 2009
An essential source of data and trend analysis on the mergers and acquisitions and financings in the medical equipment market. The report provides detailed information on M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions registered in the medical equipment industry in August 2009. The report portrays detailed comparative data on the number of deals and their value in the last six months subdivided by deal types, segments, and geographies. Additionally, the report provides information on top financial advisory firms in the medical equipment industry. Oct 2009 more ...

SynCardia’s companion driver system for artificial heart receives CE Mark
SynCardia Systems, Companion Driver System has received CE Mark approval to power the Total Artificial Heart in Europe. 20 Oct 2009

Cochlear and NXP Semiconductors collaborate to produce IC devices for advanced hearing implants
The agreement includes the definition, development and supply of ultra low power speech processor and wireless communication ICs to be used in Cochlear’s next generation products. 20 Oct 2009

Serametrix Partners with the Ludwig Institute for Cancer Research to develop and commercialize serum-based diagnostics
This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. 20 Oct 2009

Baxter receives EC approval for Celvapan H1N1 pandemic flu vaccine
Celvapan H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union. 14 Oct 2009 

Claros Diagnostics receives ISO 13485 certification for point-of-care blood-test system
Claros Diagnostics, a developer of novel point-of-care immunoassay systems, has reported the receipt of corporate ISO 13485 and CMDCAS certificates of registration issued by the National Standards Authority of Ireland (NSAI). 14 Oct 2009

Corning increases lab portfolio with acquisition of Axygen BioScience
Corning Incorporated has acquired all the shares of Axygen BioScience, Inc. and its subsidiaries from American Capital Ltd. (Nasdaq:ACAS) for approximately US$400 million in cash. 9 October 2009

French biotech companies seek UK partners: BIOMED-Connect Oct 12, London
The London Branch of Maison de la Région Languedoc-Roussillon, with support from the London Technology Network, is holding BIOMED-Connect, a business convention, on Monday October 11th from 2.00pm to 9.00pm open to all companies in the medical technology sector. 7 October 2009

Acrobot and Finsbury Orthopaedics sign co-marketing agreement
Acrobot, a developer of computer-assisted orthopaedic surgery products has announced a co-marketing arrangement with orthopaedic implants company, Finsbury. 5 October 2009

AorTech licenses heart valve to SynCardia for use in artificial heart
This agreement licenses the use of AorTech’s Elast-Eon polymer heart valve (PHV) in the SynCardia Total Artificial Heart, as well as the company’s future family of pulsatile products. 23 Sept 2009

Cardinal Health spin-off CareFusion starts trading on NYSE
CareFusion Corp. was launched as an independent, publicly traded company at the beginning of the month. CareFusion products include Pyxis automated dispensing systems, Alaris IV pumps, ChloraPrep V. Mueller surgical instruments. 21 Sept 2009

eBioscience corporation acquires NatuTec GmbH
eBioscience Corporation, a San Diego-based producer of cell analysis reagents to biotechnology laboratories has announced the acquisition of Frankfurt-based NatuTec GmbH, a distributor of high-quality biological research reagents. 21 Sept 2009.

Abbott to acquire cardiac valve device company Evalve
The acquisition provides Abbott with a presence in the growing area of non-surgical treatment for structural heart disease for a cost of up to $410 million. 21 Sept 2009

click here

IDRI licenses NanoPass microneedle technology for intradermal delivery
IDRI has licensed NanoPass' proprietary MicronJet microneedle technology for the intradermal delivery of products against a number of diseases including tuberculosis, HIV, malaria, leishmaniasis and leprosy. 10 Sept 2009

NeuroLogica announces FDA clearance for inSPira HD: portable high resolution SPECT
The inSPira HD is a battery-powered, high resolution, portable SPECT designed primarily for brain imaging. 5 Sept 2009

GE Healthcare and TomTec Imaging Systems co-operate in cardiology IT
GE Healthcare and TomTec Imaging Systems GmbH, have entered into a formal strategic co-operation contract to improve their echocardiography systems. 5 September 2009

Sectra signs multi-year contract with Nordic region’s largest radiology company
Sectra and Norwegian company Curato have signed a six-year partnership agreement for Sectra’s RIS/PACS products and services in a contract worth about SEK 100 million.

Lab21 to provide AdnaGen’s tumour cell detection system UK and Ireland
Lab21 Ltd and AdnaGen AG have entered into an exclusive service and distribution agreement for AdnaGen’s proprietary circulating tumour cell diagnostic assays in the United Kingdom and Ireland. 26 August 2009

Norway prepares for swine flu with purchase of 150 Maquet ventilators
Maquet Nordic and Puls AS have announced that they have won a SEK15 million order from the Norwegian Health Authority (Helsedirektoratet) for 140 of its Servo-i ventilators to supply hospitals across Norway during August 2009. 26 August 2009

Siemens and Impac expand co-operation in oncology information systems
The partnership will give Siemens customers access to Impac’s oncology information system (OIS) will develop interfaces for their software to interoperate. 20 August 2009 Deutsch

SonoSite completes acquisition of CardioDynamics
CardioDynamics will become a wholly-owned subsidiary of SonoSite, Inc. The transaction is valued at approximately $10.0 million. 20 August 2009

Universal flu vaccines to be developed under Inovio and US Vaccine Research Center collaboration
The VRC and Inovio will pool technologies to develop the vaccines as well as rapidly advance development of vaccine candidates targeting the emerging pandemic 2009 H1N1 swine flu strains. 20 August 2009

Omnio Healer selects Eden Biodesign for production of wound healing and anti-infection products
Eden Biodesign will provide process development and production services for Omnio Healer’s wound healing and anti-infection products for supplying the products for clinical trials. 20 August 2009

Ichor awarded US$3.3m grant to develop DNA-based Alzheimer’s disease vaccine
Ichor Medical Systems of San Diego has been awarded the grant from the US National Institute of Neurological Disorders and Stroke (NINDS) for development of the vaccine and studies required to support eventual initiation of human clinical testing. 20 August 2009

ImmunoVaccine Technologies partners with Scancell to advance DNA vaccine delivery
Canadian company IVT has signed an agreement with UK-based Scancell Ltd to explore the potential of using IVT's DepoVax delivery system for Scancell's novel ImmunoBody DNA vaccines. 17 August 2009

Turkish Hospital Group orders four RapidArc radiotherapy systems
Acibadem Healthcare Group has acquired four additional radiotherapy treatment machines from Varian Medical Systems and expanded its radiotherapy facilities with new centres in Adana and Kayseri. 17 August 2009

Sigma-Aldrich offers customisable synthetic extracellular matrix for stem cell research
Under an agreement with Glycosan BioSystems, Sigma-Aldrich can offer the HyStem platform for stem cell research. This consists of hydrogel cell culture scaffolds that provide a complex, three-dimensional environment in which cells are able to proliferate. 17 August 2009

LabCorp completes acquisition of Monogram Biosciences. 9 August 2009.

Promega expands life science products with takeover of Turner BioSystems. 9 August 2009

Leica Microsystems and A Menarini Diagnostics extend distribution agreement
Leica Microsystems GmbH and A Menarini Diagnostics Srl have signed a five-year agreement to extend their successful co-operation in distributing Leica products in Europe. 7 August 2009

Covidien to acquire Power Medical Interventions
Covidien has announced that the company has reached a definitive agreement to acquire Power Medical Interventions, Inc. a provider of computer-assisted, power-actuated surgical cutting and stapling products, for approximately $64 million. 31 July 2009

Agilent Technologies to acquire Varian for $1.5 billion
Varian, Inc has agreed to a takeover by Agilent Technologies Inc.
Agilent will pay $52 cash per share of common stock for Varian in a transaction that represents a premium of approximately 35% to Varian’s closing price on July 24, 2009. 29 July 2009

Industry experts in partnership to stimulate UK medical technology sector
The team behind the UK Access to Finance for Healthcare Technology Companies programme has today announced an alliance with two of the leading organisations in the regional medical technology sector. 2 July 2009

Rubicon Genomics introduces PicoPlex single cell whole genome amplification kit. 2 July 2009

BioSante Pharmaceuticals and Cell Genesys sign merger agreement. 2 July 2009

GE Healthcare and Geron in global agreement to commercialize stem cell drug discovery technologies. 2 July 2009

GlaxoSmithKline signs contract for Phase Forward clinical trials software. 2 July 2009

Nucletron strengthens position in cancer radiation therapy market
Dutch radiation therapy systems company Nucletron BV has announced the creation of an exclusive partnership and plan to merge with sector peer Isodose Control BV. 29 June 2009

Vivacta raises US$4.5 million to commercialise piezofilm technology for point-of-care diagnostic tests
Kent-based diagnostic technology company Vivacta has announced that following successful development of its thyroid function test, it has closed a financing round that was fully subscribed by existing investors. 18 June 2009

Aircraft Medical acquires anaesthesia monitoring technology from Morpheus Medical
Morpheus' lead product, the IoC-View, is designed to measure the level of consciousness during general anaesthesia, helping to avoid the risk of patients remaining conscious during surgery. 17 June

European medical technology sector weathering storm but expecting tougher times
A recent survey by Eucomed of medical technology manufacturers across Europe has found that the recession was having a significant negative impact on only 20% of the companies. 8 June 2009
Deutsch Francais Español

Medtronic and Lilly partner to improve delivery of diabetes education
Medtronic and Eli Lilly have entered a strategic marketing collaboration to support each other's commitment to help people with diabetes manage their blood sugar using insulin therapy. 5 June 2009

Oxford Biosensors placed in administration following funding withdrawal
Biotech Company, Oxford Biosensors has been put up for sale following the appointment of administrators. The company has developed unique technology for point-of-care electrochemical testing for lipids and other analytes, for use in the cholesterol, diabetes and renal function diagnostic testing markets. 4 June 2009 

Nanogen enters asset purchase agreement with Elitech and files for bankruptcy
Nanogen, Inc., developer of molecular and rapid diagnostic products, has executed an asset-purchase agreement with French company Elitech Group, a privately held diagnostics company, to acquire substantially all of the assets of Nanogen. 28 May 2009

RaySearch enters partnership with Siemens
Swedish company RaySearch Laboratories AB has entered into a long-term development and licensing agreement with Siemens Healthcare in which RaySearch will provide a number of treatment planning modules that will be integrated in Siemens’ syngo Suite for Oncology. 28 May 2009

Thin-film battery revenues to come from medical devices, sensors and watches
Thin-film batteries are being designed as energy storage devices for small photovoltaic or thermoelectric systems to create ultra-long-lived power sources for medical devices, sensors and watches. 19 May 2009

Biotech business model unsustainable in current economic crisis
The global biotechnology industry delivered a solid financial performance in 2008 despite worldwide economic turmoil, according to Ernst & Young's 23rd annual report on the biotech industry. 19 May 2009

GE commits US$6bn to healthcare innovation
GE has announced a US$3 billion budget for the next six years for healthcare innovation, a further US$2 billion of financing and US$1 billion in related GE technology and content to drive healthcare information technology and health in rural and underserved areas. 11 May 2009

Phase Forward signs agreement with Novo Nordisk for use of InForm for clinical trial data capture
The multi-million dollar agreement allows Danish company Novo Nordisk to use Phase Forward’s InForm electronic data capture product across all clinical trial phases, from Phases I through IV. 7 May 2009

PerkinElmer becomes exclusive distributor for ID Biological Systems’ newborn screening sample collection cards. 7 May 2009

Major Portuguese hospital selects Sectra to provide PACS
Hospital de São João, one of Portugal’s largest hospitals, has selected Sectra to provide picture archiving and communications (PACS) products and services in a multi-year contract. 7 May 2009

St Jude Medical gains EU approval for remote care system for implantable cardiac devices
St Jude Medical's Patient Care Network (PCN) is a secure, Internet-based remote care system that gathers and stores data from the implant procedure, a clinic follow-up visit or from remote follow-up transmissions of patients with implanted cardiac devices. 7 May

iSOFT wins €600,000 HIS contract in Italy
IBA Health Group Limited has announced that iSOFT has entered the Italian market with a €600,000 contract to install its hospital information system in four hospitals operated by Consorzio Regionale Servizi Sociali (CRESS), a private healthcare group. 6 May 2009

Philips acquires Canadian minimally invasive instrument supplier Traxtal
Royal Philips Electronics has announced that it has acquired Canada-based Traxtal Inc., Traxtal will become part of the Ultrasound business within the Philips Healthcare sector. 6 May 2009

SCM Microsystems completes merger with Hirsch Electronics
SCM Microsystems, Inc. based in Ismaning, Germany, has announced that it has closed its merger with Hirsch Electronics Corp. Hirsch is now a wholly-owned subsidiary of SCM. 6 May 2009

Gemalto joins SAFE-BioPharma Association
Gemalto is joining with biopharmaceutical and healthcare industry leaders to help the industry achieve its common goal of a fully electronic business environment by 2012. 23 April 2009

Rigel Pharmaceuticals and Proteros extend research collaboration
The collaboration gives Rigel access to Proteros’ Gallery Structures enabling Rigel to rapidly deliver high quality protein-ligand structural information. 23 April 2009

Parabon NanoLabs to use power of grid computing to design novel macromolecules based on synthetic DNA
Parabon Computation has spun off Parabon NanoLabs to develop nano-scale products based on designer DNA technology. It will initially focus on developing nano-scale sensors for therapeutics, diagnostics and other molecular detection systems. 9 April 2009

Cardima surgical ablation probe receives EU approval
Cardima, Inc. has received CE Mark approval for its Surgical Ablation Probe with Stabilization Sheath. The system can be used in open-chest surgery in conjunction with other procedures, or as a thoroscopic standalone, closed-chest procedure. 9 April 2009

BioAdvance Greenhouse invests $550,000 in Novira Therapeutics' antiviral drug technology
Novira is focused on the development of novel small-molecule drugs against medically-important viral targets. 8 April 2009

AtriCure’s cryoablation system receives US FDA clearance.
AtriCure's disposable cryoablation system, Cryo1, received 510(k) clearance from the US FDA for the cryosurgical treatment of cardiac arrhythmias. 8 April 2009

Physio-Control receives US clearance for Lifepak 15 monitor/defibrillator. 8 April 2009

OrSense receives EU approval for non-invasive haemoglobin and pulse oximetry monitoring system
OrSense Ltd has received a European CE Mark for its NBM-200MP, a multi-parameter sensor for non-invasive continuous hemoglobin, low signal oximetry and pulse rate measurements. 8 April 2009

Genedata strengthens TcLand Expression’s research informatics infrastructure for personalized medicine. 8 April 2009

AVEO and Biogen Idec in partnership to develop ErbB3-targeted antibodies. 8 April 2009

Aphios collaborates with VivaCell Biotechnology España to develop combination therapy for HIV latency. 8 April 2009

FluGen secures exclusive rights to novel vaccine-delivery technology
Flugen Inc., has secured rights to vaccine-delivery technology being commercialized by Ratio Inc. The easy-to-use, disposable micro-device painlessly delivers seasonal and pandemic influenza vaccines. 7 April 2009

Gene Bridges licenses recombineering technology to Daiichi Sankyo
Heidelberg-based Gene Bridges GmbH, has licenced its Red/ET recombination technology to Japanese company Daiichi Sankyo.  7 April 2009

Intel and GE form $250m alliance to develop home healthcare technology
GE and Intel Corporation have entered into an alliance to market and develop home-based health technologies that will help the elderly live independently and patients with chronic conditions manage their care at home. 6 April 2009

German medical technology sector withstanding economic crisis
Only 4% of companies in the German medical technology sector have reduced their workforce as a result of the global financial crisis, according to a survey conducted by the German Medical Technology Association, BVMed. 27 March 2009

Smart Cells establishes base in Italy
London-based Smart Cells International, the UK's longest-established cord blood stem cell processing and storage organisation, has established a base in Milan, Italy, with a joint venture with Laborest, one of Italy's leading pharmaceutical businesses. 25 March 2009

Systech to integrate serialisation expertise with Axway’s track and trace system
Axway and Systech International will partner to offer integrated systems for pharmaceutical supply chain integrity to ensure customer readiness for upcoming European and Turkish regulatory compliance. 25 March 2009

Domainex in collaboration to develop novel breast cancer drug targets
Domainex has announced a collaboration on drug-discovery programmes with the Breakthrough Breast Cancer Research Centre and The UK Institute of Cancer Research to identify and develop inhibitors of two recently validated breast cancer targets, tankyrase and IKK-epsilon. 23 March

German healthcare group selects Varian linear accelerators for radiotherapy
The HELIOS Kliniken Group is acquiring nine linear accelerators from Varian Medical Systems (NYSE: VAR), the majority of them equipped with RapidArc technology. The new machines will replace older models and add capacity that will give more patients access to the most advanced cancer care. 23 March 2009

Touch Bionics’ founder steps down
Touch Bionics, developer of the world’s first commercially available bionic hand, has announced that Director of Research and Non Executive Director, David Gow, was stepping down from the business to concentrate on his expanding role within NHS Lothian’s SMART Centre in Edinburgh. 17 March 2009

Siemens obtains full rights to the hospital information system
Siemens Medical Solutions is taking over all use and exploitation rights to the software, a clinical information system integrated with the SAP healthcare software. The system was jointly developed by the partner and forerunner companies of Siemens Medical Solutions GSD GmbH and the Austrian T-Systems. Deutsch

St Jude Medical receives EU approval for neurostimulation system for chronic angina
St Jude Medical's Genesis neurostimulation system is for managing a form of chest pain known as chronic angina pectoris, or chronic angina. It helps to control angina pain by sending mild pulses of electricity from a device implanted in the torso to nerves located along the spinal cord. 12 March 2009

Dräger receives double design award for medical devices
Two Dräger products have received the iF product design award in 2009: The Ponta beam system and the Infinity C700 for IT workstation. The iF product design award is one of the most important design competitions worldwide. 12 March 2009

StemCells to acquire drug discovery technology of Stem Cell Sciences
StemCells, Inc. is to acquire the operating subsidiaries and certain related assets of Stem Cell Sciences (SCS), a Cambridge, UK-based company focused on commercializing applications of stem cell technologies for drug discovery and regenerative medicine research. 10 March 2009

Lab21 acquires Biotec Laboratories
Lab21 Ltd of Cambridge, UK, has announced that it has purchased the majority shareholding of another UK company Biotec Laboratories Ltd, a clinical diagnostic company with particular emphasis on infectious diseases. 10 March 2009

Michelson Diagnostics raises £350K for clinical trials and growth
The money will be used to support multi-centre clinical trials of its new hand-held multi-beam optical coherence tomography (OCT) imaging probe, and also aid international commercial growth. 4 March 2009

Yorkshire attracts major investment in healthcare technologies
The Yorkshire and Humber region in northeast England has accounted for nearly 10% of first-round investments in healthcare technology in the UK, according to figures revealed at the launch of a new Access to Finance programme for local healthcare technology companies. 2 March 2009

Abbott completes takeover of Advanced Medical Optics
Abbott has announced that it has completed its acquisition of Advanced Medical Optics (AMO), which is now a wholly owned subsidiary of Abbott with the new name Abbott Medical Optics Inc. 2 March 2009

Sciemetric wins major quality control contract in medical device sector
Sciemetric Instruments, a supplier of manufacturing quality systems has been named a preferred supplier to one of the world’s largest medical device manufacturers, cementing its position in a key growth market for the company. 27 February 2009

APR acquires new drug delivery nanotechnology for innovative treatment of critical diseases
Swiss company Applied Pharma Research s.a. (APR) has acquired a nanocoating process for the preparation of new products for the treatment of several critical diseases. APR is already developing specific applications in ophthalmology and dermatology. 22 February 2009

Varian receives European approval for proton therapy system
Proton therapy allows doctors to use higher doses of radiation to control and manage tumours while significantly reducing damage to healthy tissue and vital organs. 22 February 2009

Symphogen secures €33m financing to support clinical development of antibody products
Copenhagen-based Symphogen A/S has announced the closing of €33 million (approximately US $44 million) financing. The financing will be used to mature the company’s product pipeline of antibody therapeutics, particularly within the field of oncology. 16 February 2009

Millipore acquires Guava Technologies
Millipore Corporation (NYSE: MIL), a leading provider of technologies, tools and services for the global life science industry, has entered into an agreement to acquire Guava Technologies, a provider of easy-to-use, bench top cell analysis systems. 16 February 2009

Mirna Therapeutics and UCSF to explore therapeutic potential of microRNAs
Mirna Therapeutics and the University of California, San Francisco  have entered into a collaboration agreement to evaluate the capacity of specific microRNAs to reduce or eliminate tumours in mouse models of cancer. 16 February 2009

Masimo files lawsuit against Philips for pulse oximetry patent infringement. 16 February 2009

Expression Analysis in partnership with Complement Genomics to offer genomic services in UK. 16 February 2009

Response Genetics closes UK facility
Response Genetics has announced that it is closing its Edinburgh, UK facility and increasing the capacity of its genetic testing laboratory in Los Angeles, USA. 16 February 2009

International collaboration to develop ultrasound-activated drug-delivery nanoparticles
Nanobiotix, an emerging nanomedicine company has announced that it will collaborate with the SonoDrugs project consortium to develop new nanoparticulate drug carriers that can be activated for localized drug release using focused ultrasound. 10 February 2009

Sysmex in agreement to distribute AdnaGen cancer diagnostic tests in Europe
Sysmex Europe GmbH and AdnaGen AG have entered into a non-exclusive European distribution agreement for AdnaGen proprietary CE-certified diagnostics as well as their research use only (RUO) products. 10 February 2009

EXACT Sciences in strategic relationship with Genzyme for DNA diagnostics technology
Genzyme has acquired intellectual property assets related to prenatal and reproductive health and three million shares of EXACT common stock for $24.5 million. 9 February 2009

FORMA to collaborate with Cubist to develop novel antibacterial drugs
FORMA Therapeutics has signed a collaboration agreement with Cubist Pharmaceuticals, Inc. to leverage FORMA’s transformative chemistry platform to discover novel antibacterial compounds for development by Cubist. 9 February 2009

IAVI and Algonomics to collaborate on HIV protein design project
The International AIDS Vaccine Initiative (IAVI) and Belgian company Algonomics have announced a collaboration to develop novel vaccine candidates capable of controlling HIV infection. 9 February 2009

Tomotherapy radiation treatment planning software gains FDA clearance
Swedish company RaySearch Laboratories AB and TomoTherapy Inc have announced that their jointly produced new software solution for the Tomotherapy Hi-Art linear accelerator has received clearance by the FDA for market launch in the US. 9 February 2009

Pfizer to acquire Wyeth for $68bn
Pfizer and Wyeth have entered into a definitive merger agreement under which Pfizer will acquire Wyeth in a cash-and-stock transaction worth approximately $68 billion. 4 February 2009

Graffinity and Elan in fragment-based drug-discovery collaboration
Under the terms of the agreement, Graffinity will receive technology access fees and success payments for the generation of novel small molecule hits against a number of drug targets. 4 February 2009

Ontario grants Agfa Healthcare $29.6-million to create jobs for developing radiology software
The award is to help create 100 new jobs and support existing jobs by supporting Agfa in the development of new software that allows radiologists to share digital images across a regional network. 31 January 2009

Johnson & Johnson joins Enlight Biosciences in US$52 million in novel drug discovery initiative
As a partner, Johnson & Johnson will have the opportunity to invest in the development of strategic technologies that have the potential to fundamentally transform drug discovery. 31 January 2009

Richter-Helm and Athera Biotechnologies in partnership to develop recombinant protein for cardiovascular disease
The partnership will develop and manufacture Athera's novel product for prevention of plaque rupture and athero-thrombosis through binding of the protein, Annexin A5, to endothelium. 31 January 2009

Allium Group receives CE Mark for next-generation prostatic stent
Allium Group has announced that it has been awarded CE mark for its prostatic stent, enabling commercialization of the system in the European Union and the countries that recognize the CE Mark. 31 January 2009

Philips collaborates with Bard Electrophysiology to advance cardiac arrhythmia treatment
Royal Philips Electronics has announced an agreement with Bard Electrophysiology to co-develop new clinical tools to help electrophysiologists treat patients suffering from arrhythmias. 31 January 2009

Vivacta achieves ISO13485 for quality management
Vivacta has announced that it has achieved compliance with ISO13485, an important step towards the successful commercialisation of its ultrasensitive point-of-care immunochemistry system. 31 January 2009

Crospon receives CE Mark for EndoFLIP System
Irish medical device developer Crospon has announced that its EndoFLIP system has received CE Mark certification from the NSAI (National Standards Authority of Ireland), the Irish Notified Body, in accordance with the European Medical Device Directive. 31 January 2009

St Jude's Libra deep brain stimulation systems for Parkinson’s disease gains EU approval
St Jude Medical has received the European CE Mark approval for its Libra and LibraXP deep brain stimulation (DBS) systems, the company's first products in the DBS market. 31 January 2009

e-Therapeutics enters drug discovery partnership with Cresset BioMolecular Discovery
e-Therapeutics plc (AIM: ETX) has entered into an agreement with UK-based Cresset BioMolecular Discovery Ltd, a specialist in molecular field technology. The initial focus of the collaboration will combine e-Therapeutics’ computational platform with Cresset’s advanced technology in chemical comparison. 27 January 2009

Morphotek in evaluation agreement with University Hospital Heidelberg
The evaluation will advance the company's efforts in the discovery and development of therapeutic antibodies in oncology. 25 January 2009

Michelson Diagnostics singled out as high-growth company
UK-based Michelson Diagnostics has been singled out as a company with high growth potential by two leading investor organisations. 25 January 2009

New Venture Partners and Unilever Ventures invest in personalised weight management system
New Venture Partners LLC, the global venture capital firm dedicated to corporate technology spinouts, and Unilever Ventures, the early stage venture arm of Unilever, have jointly invested in MiLife, a company focused on providing technology solutions for personalised weight management. 25 January 2009

UK healthcare technology companies urged to tap into growing Middle East markets
UK Trade & Investment (UKTI) and the Association of British Healthcare Industries (ABHI) are urging UK healthcare technology businesses to capitalise on demand in the fast growing Middle East market. 23 January 2009

ICON completes takeover of Beacon Bioscience
Dublin-based ICON plc has completed the acquisition of the remaining 30% shareholding of Beacon Bioscience Inc. 22 January 2009

Boston Scientific acquires Labcoat's stent technology
Boston Scientific Corporation has acquired Labcoat Limited, a privately held, development-stage drug-eluting stent technology company located in Galway, Ireland. Terms of the acquisition were not disclosed. 16 January 2009

Sigma-Aldrich acquires Seppro depletion technology from GenWay Biotech
Sigma-Aldrich has expanded its proteomics offerings with the acquisition of Seppro affinity depletion technology and a library of 700 avian-derived antibodies from GenWay Biotech, Inc. Seppro depletion products enable scientists to measure more precisely the expression of protein biomarkers from a range of mammalian and plant biological samples. 16 January 2009

ExonHit Therapeutics expands strategic collaboration with Allergan
ExonHit Therapeutics has announced a reinforcement of its existing drug discovery collaboration with Allergan Sales. The collaboration includes antibody discovery within the scope of the research activities and encompasses revised commercial terms. 16 January 2009

PerkinElmer launches Operetta high content screening system
PerkinElmer, Inc., has launched its Operetta system, a benchtop instrument that provides high content screening (HCS) and high content analysis (HCA) capabilities to drug discovery and cellular science research laboratories.

Abbott acquires Ibis Biosciences
Abbott has exercised its option to purchase the remaining equity ownership in Ibis Biosciences, Inc., an Isis subsidiary, for a closing purchase price of $175 million. 12 January 2009

CMPMedica signs global contract with iSOFT for drug information decision support tools
CMPMedica's information solution will power iSOFT's suite of decision-support tools. These tools enable healthcare professionals to make better informed decisions at the point of care and thus improve patient outcomes. 9 January 2009

AorTech signs licensing agreement for medical device components
AorTech International plc has announced a technology license and material supply agreement with a leading manufacturer of a life-sustaining circulatory support system. 9 January 2009

Agfa wins contract from Antwerp University Hospital for cardiovascular system
Antwerp University Hospital, Belgium, has awarded Agfa HealthCare a contract for its IMPAX Cardiovascular solution. The contract will provide enterprise-wide access to cardiology patient records to meet the high volume diagnostic needs. 6 January 2009

Business news:  Now | 2008 | 2007 | 2006 | 2005

To top

To top